APA (7th ed.) Citation

Nakayama, S., Yonekura, S., Nakajima, S., & Kabashima, K. (2025). Nemolizumab as a Novel Therapeutic Option for Refractory Prurigo Chronica Multiformis: A Case Report. Wiley. https://doi.org/10.1111/ijd.17821

Chicago Style (17th ed.) Citation

Nakayama, Shota, Satoru Yonekura, Saeko Nakajima, and Kenji Kabashima. Nemolizumab as a Novel Therapeutic Option for Refractory Prurigo Chronica Multiformis: A Case Report. Wiley, 2025. https://doi.org/10.1111/ijd.17821.

MLA (9th ed.) Citation

Nakayama, Shota, et al. Nemolizumab as a Novel Therapeutic Option for Refractory Prurigo Chronica Multiformis: A Case Report. Wiley, 2025. https://doi.org/10.1111/ijd.17821.